Uzbekistan Opens 60-Day Fast Track for Ultrasound Device Registration

On June 15, 2026, Uzbekistan’s drug regulator UZDRA announced a green registration channel for ultrasound imaging equipment, introducing a parallel process that combines document pre-review with on-site inspection for eligible portable and bedside systems. For manufacturers, distributors, regulatory teams, and procurement-facing businesses, the key point is not only the shorter timeline—from the usual 180 days to 60 calendar days—but also the fact that eligibility is tied to ISO 13485 and IEC 62359 compliance, with the first batch of interested applicants required to file an expression of interest by July 10.

What the new pathway formally covers

According to the disclosed information, the new fast-track pathway applies to portable and bedside ultrasound devices described under the Ultrasound Metrics category. UZDRA stated that the mechanism will run document pre-review and on-site verification in parallel rather than sequentially. For products that meet the stated conditions, including compliance with ISO 13485 and IEC 62359, the registration period is reduced from the standard 180 days to 60 calendar days. The announcement was made on June 15, 2026, and the first group of applicable companies must submit an intention filing by July 10.

Where the industry may feel the effect first

Regulatory and market-entry teams face a narrower preparation window

Analysis shows the most immediate impact is likely on regulatory affairs and market-entry planning. A shorter registration cycle can change launch sequencing, but only for companies that can document conformity with the stated standards and respond to a parallel review structure. What deserves closer attention is whether internal documentation, inspection readiness, and submission timing are aligned quickly enough to make use of the 60-day pathway.

Manufacturers of portable and bedside systems may need faster cross-functional coordination

From an industry perspective, manufacturers that target portable or bedside ultrasound equipment are the most directly affected group. The potential impact is not simply faster approval, but a compressed coordination cycle across quality, technical documentation, and site-readiness functions because pre-review and on-site checks are no longer separated into longer sequential stages.

Distributors and channel partners may need to revisit go-to-market timing

Observably, businesses responsible for local commercialization, distribution planning, or customer communication may need to reassess delivery expectations and registration-linked launch schedules. If a product qualifies for the green channel, commercial planning could move faster; if it does not, the standard timeline may still shape market entry. The practical issue is therefore how channel partners communicate timing assumptions without treating the shorter pathway as automatic.

Procurement-facing teams should watch qualification status, not just policy headlines

For procurement-side stakeholders and end-use buyers, the announcement may matter because registration timing can influence product availability and project scheduling. Analysis shows, however, that the relevant variable is whether a specific device and supplier actually enter and complete the fast-track route, rather than the existence of the route alone.

What companies should watch now

Check whether the product scope clearly matches the announced category

The first practical step is to confirm whether a device fits the portable or bedside ultrasound scope referenced in the announcement. Businesses should avoid assuming that all ultrasound products are covered in the same way when the disclosed wording points to a defined equipment category.

Review compliance evidence against the named standards

Companies planning to participate should focus on whether their quality management and technical compliance materials are ready to support claims under ISO 13485 and IEC 62359. Since those standards are explicitly named in the announcement, they are central to screening for pathway suitability.

Prepare for a parallel review logic, not a traditional sequence

What deserves closer attention is the operational implication of document pre-review and on-site inspection running in parallel. This can shorten overall timing, but it can also reduce room for delay between submission, inspection preparation, and cross-team responses. Businesses should therefore align regulatory, quality, and local coordination efforts around a tighter calendar.

Do not miss the first-batch filing deadline

The stated July 10 intention-filing deadline is a near-term decision point. Even without further disclosed procedural detail, companies that see this route as relevant need to assess quickly whether they are ready to enter the first batch or whether they should continue monitoring later implementation signals.

How this announcement is best understood at this stage

Analysis shows this is best read as a concrete regulatory process adjustment for a defined product segment, but not yet as a fully proven long-term market shift. The confirmed facts establish a shorter route and a near-term application window; they do not, by themselves, confirm how broadly the mechanism will be used, how many applicants will qualify, or whether similar acceleration will extend to other device categories. It is more appropriate to understand this as a targeted signal that Uzbekistan is testing a faster registration approach for qualifying ultrasound equipment, while the industry continues to watch implementation details.

Why the market still needs a measured reading

At this point, the industry relevance lies in the combination of three confirmed elements: a named fast-track channel, defined standard-based eligibility, and a registration cycle shortened to 60 calendar days for applicable products. For affected businesses, that is meaningful enough to trigger internal review, but not enough to justify broad assumptions about all ultrasound products or all future registrations. A neutral reading is that the policy creates an actionable short-term window for some companies and a longer-term signal worth monitoring for the wider medical device registration environment.

Basis of this article and points for continued verification

This article is based on the user-provided news title, event date, and event summary. For this type of development, relevant source categories typically include official regulatory announcements, company notices, industry association updates, authoritative media coverage, and standards organization documents. No specific official source link was provided in the input, so the exact source document still requires continued verification. Follow-up attention should focus on any further UZDRA wording on application procedures, scope interpretation, and implementation details for the first batch after the July 10 intention-filing deadline.